Navy SEAL’s Radical Therapy Push – Will It Save Lives?

Field of American flags waving in the breeze

A decorated Navy SEAL who survived one of America’s deadliest special operations missions is now leading a bipartisan charge to give veterans access to psychedelic therapies—treatments that he credits with saving his life after traditional medicine failed.

Story Highlights

Marcus Luttrell, “Lone Survivor” author, publicly advocates for psychedelic treatments after personal success with ibogaine and 5-MeO-DMT
His twin brother, Congressman Morgan Luttrell (R-TX), successfully passed legislation mandating DOD clinical trials for psychedelic therapies
Veterans Exploring Treatment Solutions nonprofit has funded over 300 special operations veterans for psychedelic therapy at retreat centers
Approximately 20 veterans die by suicide daily, driving urgent demand for alternatives to traditional PTSD treatments

SEAL Survivors Turn to Controversial Treatments

Marcus Luttrell survived Operation Red Wings in 2005, a mission that claimed 19 American lives and became the subject of his bestselling book “Lone Survivor.” Years later, struggling with PTSD and traumatic brain injuries, Luttrell and his twin brother Morgan traveled to Mexico in 2017-2018 for psychedelic treatments using ibogaine and 5-MeO-DMT. These Schedule I controlled substances remain illegal in the United States, forcing veterans to seek treatment abroad. The Luttrell brothers report dramatic improvements in symptoms that traditional antidepressants and therapy could not address, prompting their public advocacy.

From Personal Experience to Federal Policy

Morgan Luttrell’s election to Congress as a Republican representative from Texas positioned him to translate personal experience into legislative action. In 2025, he successfully shepherded an amendment through both chambers of Congress requiring the Department of Defense to conduct clinical trials examining psychedelic therapies for active duty military personnel. The legislation’s passage surprised even its sponsor, given psychedelics’ controversial Schedule I classification. Congressman Luttrell emphasized the need to “take that next step of evolution in the treatment of our veterans and our service members,” allowing science to guide policy rather than stigma.

Nonprofit Fills Gap While Government Lags

Marcus Capone, a medically-retired SEAL Team SIX operator, founded Veterans Exploring Treatment Solutions (VETS) in 2019 alongside his wife Amber. The nonprofit provides grants and resources for veterans seeking psychedelic-assisted therapy, having funded treatments for over 300 special operations veterans at retreat centers in Mexico. Capone emphasizes the urgent need to “bring those medicines here to the U.S.” given that 20 veterans die by suicide every day. The organization serves veterans for whom traditional Western medicine approaches proved insufficient, offering what many describe as a last-resort option that produced life-changing results.

Cautious Optimism from Policy Experts

Harvard University recently convened experts including VA officials and former CDC directors to discuss expanding veteran access to psychedelic-assisted therapy. The panel emphasized balancing speed with caution, acknowledging both the therapeutic potential and regulatory challenges presented by Schedule I classification. Former Texas Governor Rick Perry, a vocal supporter and friend of Marcus Luttrell, has also advocated for psychedelic research. The federally-mandated DOD clinical trials represent significant institutional legitimacy for treatments long dismissed by mainstream medicine. Success could lead to FDA approval, fundamentally reshaping how the military-medical complex addresses service-related mental health conditions and potentially extending benefits to civilian populations.

This development reflects growing frustration with government institutions that have failed to adequately address the veteran mental health crisis despite decades of awareness. The bipartisan support signals recognition that current approaches are insufficient, though questions remain about long-term efficacy, risks, and implementation timelines. Veterans continue traveling to foreign countries for treatments that remain illegal domestically—a situation many see as government failure to prioritize those who served.